Bicycle Therapeutics to Present Pharmacokinetic and Safety E

CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--May 23, 2024--

Related Keywords

United States , Massachusetts , Paris , France General , France , Chicago , Illinois , United Kingdom , Saclay , Cambridge , Cambridgeshire , American , Gustave Roussy , Justin Bader , Kevin Lee , Yohann Loriot , Stephanie Yao , Deborah Elson , Drug Administration , American Society For Clinical Oncology , Corporate Communications , International Nonproprietary Name , Nasdaq , Exchange Commission , Bicycle Toxin Conjugates , Clinical Oncology , Annual Meeting , Fast Track Designation , Track Designation , Safety Data , Session Title , Developmental Therapeutics , Molecularly Targeted Agents , Lead Author , Registrational Phase , Bicycle Toxin Conjugate , Genitourinary Cancer , Institut De Canc , Toxin Conjugate , Bicycle Tumor Targeted Immune Cell Agonist , Radio Conjugates , Private Securities Litigation Reform Act , Quarterly Report , Investor Relations , Bicycle Therapeutics , Business Wire ,